Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Le Page

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
The Lancet Regional Health. Europe|November 25, 2022
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort studySarah Wilson, Floriane Calocer, Fabien Rollot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 3, 2020
Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS studySandra Vukusic, Iuliana Ionescu, Catherine Cornu, et al.
Brain : a Journal of Neurology|March 3, 2023
The radiologically isolated syndrome: revised diagnostic criteriaChristine Lebrun-Frénay, Darin T Okuda, Aksel Siva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2019
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MSCaroline Lavie, Fabien Rollot, Françoise Durand-Dubief, et al.
JAMA Neurology|August 21, 2023
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical TrialChristine Lebrun-Frénay, Aksel Siva, Maria Pia Sormani, et al.
JAMA Neurology|February 26, 2014
Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective studyMikael Cohen, Elisabeth Maillart, Ayman Tourbah, et al.
BMC Neurology|October 28, 2025
Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in FranceSarah Wilson, Emmanuelle Leray, Floriane Calocer, et al.
JAMA|March 10, 2025
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical TrialEric Thouvenot, David Laplaud, Christine Lebrun-Frenay, et al.
Multiple Sclerosis and Related Disorders|November 29, 2025
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysisLisa G Schoof, Brit Ellen Rød, Sahla El Mahdaoui, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple SclerosisMarie Mainguy, Romain Casey, Sandra Vukusic, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
The Lancet Regional Health. Europe|November 25, 2022
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort studySarah Wilson, Floriane Calocer, Fabien Rollot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 3, 2020
Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS studySandra Vukusic, Iuliana Ionescu, Catherine Cornu, et al.
Brain : a Journal of Neurology|March 3, 2023
The radiologically isolated syndrome: revised diagnostic criteriaChristine Lebrun-Frénay, Darin T Okuda, Aksel Siva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2019
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MSCaroline Lavie, Fabien Rollot, Françoise Durand-Dubief, et al.
JAMA Neurology|August 21, 2023
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical TrialChristine Lebrun-Frénay, Aksel Siva, Maria Pia Sormani, et al.
JAMA Neurology|February 26, 2014
Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective studyMikael Cohen, Elisabeth Maillart, Ayman Tourbah, et al.
BMC Neurology|October 28, 2025
Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in FranceSarah Wilson, Emmanuelle Leray, Floriane Calocer, et al.
JAMA|March 10, 2025
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical TrialEric Thouvenot, David Laplaud, Christine Lebrun-Frenay, et al.
Multiple Sclerosis and Related Disorders|November 29, 2025
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysisLisa G Schoof, Brit Ellen Rød, Sahla El Mahdaoui, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple SclerosisMarie Mainguy, Romain Casey, Sandra Vukusic, et al.
Pageof 7